Egbert Madamba

A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis

Tae Gyu Oh, Susy M. Kim, Cyrielle Caussy et al. · Cell Metabolism · 2020 · 336 citations · Full text

Life Sciences, Immunology, Microbiology +12

A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes

Veeral Ajmera, Sandra Cepin, Kaleb Tesfai et al. · Journal of Hepatology · 2022 · 296 citations · Full text

Medicine, Internal Medicine, Pathology +16

Fibrosis Progression Rate in Biopsy-Proven Nonalcoholic Fatty Liver Disease Among People With Diabetes Versus People Without Diabetes: A Multicenter Study

Daniel Q. Huang, Laura Wilson, Cynthia Behling et al. · Gastroenterology · 2023 · 167 citations · Full text

Medicine, Internal Medicine, Pathology +17

MRE combined with FIB-4 (MEFIB) index in detection of candidates for pharmacological treatment of NASH-related fibrosis

Jinho Jung, Rohan Loomba, Kento Imajo et al. · Gut · 2020 · 147 citations · Full text

Medicine, Pathology, Radiology +17

Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD

Beom Kyung Kim, Nobuharu Tamaki, Kento Imajo et al. · Journal of Hepatology · 2022 · 100 citations · Full text

Medicine, Internal Medicine, Pathology +11